Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

43 citing papers in PubMed.

1. Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.Non-coding RNA · 2025
   Review
2. Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.International journal of molecular sciences · 2023
   Article
3. MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer's disease.Life science alliance · 2023
   Article
4. Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain.International journal of molecular sciences · 2023
   Review
5. 3D genome-selected microRNAs to improve Alzheimer's disease prediction.Frontiers in neurology · 2023
   Article
6. Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer's disease.Frontiers in genetics · 2022
   Article
7. Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans.Metabolic brain disease · 2021
   Article
8. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.Non-coding RNA · 2021
   Article
9. CircRNAs: role in human diseases and potential use as biomarkers.Cell death & disease · 2021
   Review
10. A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.Frontiers in molecular neuroscience · 2021
    Review
11. microRNA-Based Biomarkers in Alzheimer's Disease (AD).Frontiers in neuroscience · 2020
    Review
12. Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease.Metabolic brain disease · 2020
    Article
13. Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.Virusdisease · 2018
    Review
14. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).Cellular and molecular neurobiology · 2018
    Article
15. Gut microbiota, epigenetic modification and colorectal cancer.Iranian journal of microbiology · 2017
    Review
16. Alterations in micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1.Journal of Alzheimer's disease & Parkinsonism · 2017
    Article
17. Periodontitis, Microbiomes and their Role in Alzheimer's Disease.Frontiers in aging neuroscience · 2017
    Article
18. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.Oncotarget · 2016
    Article
19. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Biochimica et biophysica acta · 2016
    Review
20. Natural and Synthetic Neurotoxins in Our Environment: From Alzheimer's Disease (AD) to Autism Spectrum Disorder (ASD).Journal of Alzheimer's disease & Parkinsonism · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as